Search form Search About Us Profile & Mission Our Strategy Leadership Team Company History Our Products Cumberland Emerging Technologies Investor Relations Corporate Update Corporate Governance Management Board of Directors Stock Information Analyst Coverage Historic Stock Lookup Ownership Profile Financial Information SEC Fillings Annual Reports Quarterly Results Key Ratios Events Calender Investor FAQ's News Releases Press Releases Corporate Updates In the News Contact IR News Contact Us Corporate Headquarters Cumberland Pharmaceuticals Inc. 2525 West End Avenue, Suite 950 Nashville, Tennessee 37203 Phone: (615) 255-0068 Toll Free: (877) 484-2700 Fax: (615) 255-0094 info@cumberlandpharma.com *For directions to us, please see Location Employment Opportunities employment@cumberlandpharma.com Investor Relations investors@cumberlandpharma.com Business Development development@cumberlandpharma.com Wholesaler Customer Service Phone: (877) 274-7200 Fax: (614) 652-9127 Medical Information This website is not for medical emergencies. If you are a patient, caregiver or healthcare professional and need product related information, please visit our Products page, which will link you to product-specific websites. Adverse Event Reporting Toll Free Phone: (866) 767-5077 (For healthcare professionals only) Providing Solutions Cumberland Pharmaceuticals is a unique company with quality products that deliver real patient solutions every day. Quality Products Acetadote is an FDA-Approved IV treatment for Acetaminophen overdose. Currently being used in more than 3,000 U.S. hospitals. Improving Care Caldolor is the first injectable treatment for pain and fever approved in the U.S. Driving Success Kristalose is the only prescription laxative product available in a powder formulation. Expanding Pipeline Hepatoren currently in Phase II, is an injection intended to treat patients suffering from hepatorenal syndrome. Learn more about recent company developments from Cumberland Pharmaceuticals’ Founder and CEO A.J. Kazimi. Read Message Recent News September 17, 2015 Cumberland Pharmaceuticals and Clinigen Group Announce Strategic Alliance August 4, 2015 Cumberland Pharmaceuticals Reports Second Quarter & Year To Date 2015 Financial Results View All CPIX (Common Stock) Exchange: NASDAQ Open: 5.87 Price: 6 Change: +0.26 (4.53%) Volume: 2,400 Data as of Friday 10/09/2015 03:57 PM E.T. Minimum 20 minute delay Cumberland Pharmaceuticals Inc. 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203 ... Site MapPrivacy PolicyTerms & Conditions